Farther Finance Advisors »

Sab Biotherapeutics shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2026-09-30 $67 21 3.19

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Apple Stock (AAPL)
Vanguard S&p 500 Etf Etf (VOO)
Nvidia Corporation Stock (NVDA)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Dimensional International Value Etf Etf (DFIV)
Schwab U.s. Large-cap Etf Etf (SCHX)
Vanguard Morningstar Value Etf Etf (VTV)
Microsoft Corp Stock (MSFT)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Amazon Stock (AMZN)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Invesco Qqq Trust Series I Etf (QQQ)

View all positions for Farther Finance Advisors

Top funds holding Sab Biotherapeutics

Caligan Partners
Vivo Capital
Perceptive Advisors
Adage Capital Partners GP
RA Capital Management
Balyasny Asset Management
BlackRock
Vanguard Capital Management
Commodore Capital
Millennium Management
Spruce Street Capital
Sessa Capital IM
Affinity Asset Advisors
Boothbay Fund Management
Geode Capital Management

View all funds holding Sab Biotherapeutics